Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NORMOFLUDIL FORTE 600 MG COMPRIMIDOS DISPERSABLES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NORMOFLUDIL FORTE 600 MG COMPRIMIDOS DISPERSABLES

Approved

STANDARD

NORMOFLUDIL FORTE 600 MG COMPRIMIDOS DISPERSABLES

Laboratorios Normon S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 7, 2021
Approval ID: 61b2d29935cbbfbd
Company: Laboratorios Normon S.A.
Type: Standard

Approval Details

Approval Id: 61b2d29935cbbfbd
Drug Cima Aemps Name: NORMOFLUDIL FORTE 600 MG COMPRIMIDOS DISPERSABLES
Register Number: 85822
Holder Company Name: Laboratorios Normon S.A.
Marketing Company Name: Laboratorios Normon S.A.
Authorization Date: 2021-03-07
Dosage Form: COMPRIMIDO DISPERSABLE
Dose: 600 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratorios Normon S.A.

Active Ingredients

ACETILCISTEINA

600 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 7, 2021

Approval ID

61b2d29935cbbfbd

Type

Standard

Back to CIMA-AEMPS Approvals